203 related articles for article (PubMed ID: 34409031)
1. LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells.
Chen L; Sun L; Dai X; Li T; Yan X; Zhang Y; Xiao H; Shen X; Huang G; Xiang W; Zhang Y; Tan D; Yang S; Nie Y; Huang X; Lian J; He F
Front Cell Dev Biol; 2021; 9():687524. PubMed ID: 34409031
[TBL] [Abstract][Full Text] [Related]
2. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
Zhang N; Wu Y; Lyu X; Li B; Yan X; Xiong H; Li X; Huang G; Zeng Y; Zhang Y; Lian J; Ni Z; He F
Cancer Lett; 2017 Nov; 409():81-90. PubMed ID: 28889000
[TBL] [Abstract][Full Text] [Related]
3. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
[TBL] [Abstract][Full Text] [Related]
5. An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells.
Xie Y; Fan S; Ni D; Wan W; Xu P; Ding Y; Zhang R; Lu J; Zhang N; Zhang Y; Xiao W; Zhao K; Luo C
Bioorg Med Chem; 2023 Apr; 84():117262. PubMed ID: 37018878
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384.
Chen Z; Yu C; Zhan L; Pan Y; Chen L; Sun C
Am J Cancer Res; 2016; 6(10):2299-2309. PubMed ID: 27822419
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CRNDE promotes the epithelial-mesenchymal transition of hepatocellular carcinoma cells via enhancing the Wnt/β-catenin signaling pathway.
Zhu L; Yang N; Du G; Li C; Liu G; Liu S; Xu Y; Di Y; Pan W; Li X
J Cell Biochem; 2019 Feb; 120(2):1156-1164. PubMed ID: 30430650
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
10. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
11. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma.
Tao H; Zhang Y; Li J; Liu J; Yuan T; Wang W; Liang H; Zhang E; Huang Z
Mol Ther Oncolytics; 2023 Mar; 28():88-103. PubMed ID: 36699616
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma.
Li X; Zhou Y; Yang L; Ma Y; Peng X; Yang S; Li H; Liu J
J Cell Physiol; 2020 Apr; 235(4):3402-3413. PubMed ID: 31549407
[TBL] [Abstract][Full Text] [Related]
14. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
15. lncRNA-POIR promotes epithelial-mesenchymal transition and suppresses sorafenib sensitivity simultaneously in hepatocellular carcinoma by sponging miR-182-5p.
Chen BW; Zhou Y; Wei T; Wen L; Zhang YB; Shen SC; Zhang J; Ma T; Chen W; Ni L; Wang Y; Bai XL; Liang TB
J Cell Biochem; 2021 Jan; 122(1):130-142. PubMed ID: 32951268
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Li X; Liang S; Fei M; Ma K; Sun L; Liu Y; Liu L; Wang J
Int J Biol Sci; 2024; 20(2):718-732. PubMed ID: 38169579
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CRNDE promotes heptaocellular carcinoma cell proliferation by regulating PI3K/Akt /β-catenin signaling.
Tang Q; Zheng X; Zhang J
Biomed Pharmacother; 2018 Jul; 103():1187-1193. PubMed ID: 29864897
[TBL] [Abstract][Full Text] [Related]
18. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
19. Egr-1 regulates irradiation-induced autophagy through Atg4B to promote radioresistance in hepatocellular carcinoma cells.
Peng WX; Wan YY; Gong AH; Ge L; Jin J; Xu M; Wu CY
Oncogenesis; 2017 Jan; 6(1):e292. PubMed ID: 28134935
[TBL] [Abstract][Full Text] [Related]
20. The lncRNA CRNDE is regulated by E2F6 and sensitizes gastric cancer cells to chemotherapy by inhibiting autophagy.
Zhang F; Chen Q; Chen P; Liu C; Wang H; Zhao L
J Cancer; 2022; 13(10):3061-3072. PubMed ID: 36046639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
